RNA circles with minimized immunogenicity as potent PKR inhibitors

Mol Cell. 2022 Jan 20;82(2):420-434.e6. doi: 10.1016/j.molcel.2021.11.019. Epub 2021 Dec 23.

Abstract

Exon back-splicing-generated circular RNAs, as a group, can suppress double-stranded RNA (dsRNA)-activated protein kinase R (PKR) in cells. We have sought to synthesize immunogenicity-free, short dsRNA-containing RNA circles as PKR inhibitors. Here, we report that RNA circles synthesized by permuted self-splicing thymidylate synthase (td) introns from T4 bacteriophage or by Anabaena pre-tRNA group I intron could induce an immune response. Autocatalytic splicing introduces ∼74 nt td or ∼186 nt Anabaena extraneous fragments that can distort the folding status of original circular RNAs or form structures themselves to provoke innate immune responses. In contrast, synthesized RNA circles produced by T4 RNA ligase without extraneous fragments exhibit minimized immunogenicity. Importantly, directly ligated circular RNAs that form short dsRNA regions efficiently suppress PKR activation 103- to 106-fold higher than reported chemical compounds C16 and 2-AP, highlighting the future use of circular RNAs as potent inhibitors for diseases related to PKR overreaction.

Keywords: PKR; PKR inhibitor; T4 RNA ligase; circular RNA; circular RNA structure; dsRNA; group I intron; immune response; permuted Anabaena pre-tRNA group I intron; phage T4 thymidylate synthase gene.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Bacteriophage T4 / enzymology
  • Bacteriophage T4 / genetics
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Immunity, Innate / drug effects
  • Introns
  • Nucleic Acid Conformation
  • Protein Kinase Inhibitors / immunology
  • Protein Kinase Inhibitors / pharmacology*
  • RNA Ligase (ATP) / genetics
  • RNA Ligase (ATP) / metabolism
  • RNA Precursors / genetics
  • RNA Precursors / metabolism
  • RNA, Circular / genetics
  • RNA, Circular / immunology
  • RNA, Circular / pharmacology*
  • Thymidylate Synthase / genetics
  • Thymidylate Synthase / metabolism
  • Viral Proteins / genetics
  • Viral Proteins / metabolism
  • eIF-2 Kinase / antagonists & inhibitors*
  • eIF-2 Kinase / metabolism

Substances

  • Protein Kinase Inhibitors
  • RNA Precursors
  • RNA, Circular
  • Viral Proteins
  • Thymidylate Synthase
  • EIF2AK2 protein, human
  • eIF-2 Kinase
  • RNA Ligase (ATP)